Financials
- Market Capitalization 2.17 B
- Employee 128
- Founded 2012
- CEO N/A
- Website www.auriniapharma.com
- Headquarter Alberta, Canada
- FIGI BBG000BCRJM5
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
7.71
市销率
7.82
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1933 | MLYS Mineralys Therapeutics, Inc. - Common Stock | 25.34 USD | -2.58% | -2.58% | -6.15% | -37.23% | 2.24 B USD | ||
| 1940 | URGN UroGen Pharma Ltd. - Ordinary Shares | 45.50 USD | -0.96% | -1.77% | +10.71% | +139.47% | 2.22 B USD | ||
| 1972 | VCEL Vericel Corporation - Common Stock | 41.03 USD | -0.36% | -3.82% | -11.93% | +12.87% | 2.10 B USD | ||
| 1973 | NBTX Nanobiotix S.A. - ADSs | 42.25 USD | -6.44% | -3.96% | +12.61% | +354.30% | 2.05 B USD |